<DOC>
	<DOCNO>NCT00963846</DOCNO>
	<brief_summary>Huperzine natural plant product procognitive property patient Alzheimer 's disease . Cognitive difficulty hamper function schizophrenia well . The present study investigate whether huperzine improve cognition function patient schizophrenia .</brief_summary>
	<brief_title>Huperzine Cognitive Functional Impairment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Huperzine A</mesh_term>
	<criteria>1 . Psychiatric diagnosis schizophrenia accord SCIDIV . 2 . Currently treat antipsychotic medication . 3 . Has tolerate current antipsychotic treatment adequately . 4 . Has receive adequate trial antipsychotic ( least 3 month least 300 mg/d CPZ equivalent ) . 5 . Has receive current psychotropic medication ( ) least 8 week . 6 . Has receive current dos psychotropic medication ( ) least 4 week . 7 . Has clinically stable least 12 week . 8 . No moderate severity ( 4 17 scale ) PANSS positive item . 9 . No 15 total PANSS negative symptom item . 10 . SimpsonAngus Scale total score &lt; 7 . 11 . Calgary Depression Scale Schizophrenia total score &lt; 11 . 12 . Submaximal performance least one follow MATRICS component ( letternumber span &lt; 20 OR HVLT total &lt; 31 OR CPT dprime &lt; 3.47 ) . 13 . Score &gt; 1 SD age , gender , educationadjusted normal control mean MATRICS composite 14 . Good general health additional disease expect interfere study . 15 . Fluent English . 16 . Age 1855 . 17 . Adequate visual auditory acuity allow neuropsychological testing . 18 . Able ingest oral medication . 19 . Not pregnant lactating ( woman childbearing potential must use medically accept method birth control ) . 20 . Onset schizophrenia prior age 45 . 21 . Available informant knowledgeable subject 's current functioning . 22 . Informed consent obtain subject prior entry study . 1 . Poor read skill ( raw score MATRICS Wechsler Test Adult Reading &lt; 6 ) . 2 . History systemic cancer within 5 year . 3 . Use investigational drug within 30 day prior screen visit . 4 . Use cholinesterase inhibitor ( galantamine , rivastigmine , donepezil , tacrine ) within 4 week screen . 5 . Any clinically significant laboratory test abnormality screening test ( hematology , chemistry , urinalysis , EKG ) . Clinically significant LFT elevation define &gt; 2x upper limit normal . 6 . Any significant neurologic disease include Alzheimer 's disease , parkinson 's disease , stroke , huntington 's disease , normal pressure hydrocephalus , brain tumor , progressive supranuclear palsy , seizure disorder , subdural hematoma , multiple sclerosis , history head injury loss consciousness great one day within past 5 year , residual deficit . 7 . Use antihypertensive agent frequent CNS side effect ( e.g . clonidine , propranolol ) within 4 week prior screen visit . 8 . Use medication know alter drug absorption metabolism ( e.g . probenecid , cimetidine , antifungal agent , erythromycin , rifampin , anticonvulsant ) within 4 week prior screen visit . 9 . History peptic ulcer disease within 2 year . 10 . History myocardial infarction , significant cardiovascular disease , congestive heart failure within 6 month , history hepatic renal insufficiency , insulinrequiring diabetes uncontrolled diabetes mellitus . 11 . Clinically significant cardiac arrhythmia , rest pulse less 50 . 12 . Present use use 4 week prior screen antiparkinsonian anticholinergic medication ( e.g . Sinemet , amantadine , bromocriptine , pergolide , selegiline , atropine , scopolamine , benztropine , trihexyphenidyl , hydroxyzine , diphenhydramine ) . 13 . Use narcotic analgesic within 4 week prior screen visit . 14 . History alcohol substance abuse dependence within past 2 year ( DSMIV criterion ) . 15 . Receiving CYP 1A2 inhibitor certain SSRIs ( exclude # 4 ) cimetidine , methoxsalen , quinolones , furafylline , moclobemide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>cognition</keyword>
	<keyword>function</keyword>
</DOC>